Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis

INTRODUCTION: Chorea, a common clinical manifestation of Huntington’s disease (HD), involves sudden, involuntary movements that interfere with daily functioning and contribute to the morbidity of HD. Tetrabenazine and deutetrabenazine are FDA-approved to treat chorea associated with HD. Compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Claassen, Daniel O., Ayyagari, Rajeev, Garcia-Horton, Viviana, Zhang, Su, Alexander, Jessica, Leo, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857359/
https://www.ncbi.nlm.nih.gov/pubmed/34905160
http://dx.doi.org/10.1007/s40120-021-00309-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857359/
https://www.ncbi.nlm.nih.gov/pubmed/34905160
http://dx.doi.org/10.1007/s40120-021-00309-5

Ejemplares similares